Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Finlabo SIM Spa
|
$10.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Norda ASA Receives Notification of Claims under Sellers Warranty from DiaSorin SpA's DiaSorin Ireland Ltd, DiaSorin AB and DiaSorin Inc
Norda ASA announced that it has received a notice from the purchaser of the business of NorDiag, DiaSorin SpA's DiaSorin Ireland Ltd, DiaSorin AB and DiaSorin Inc. The requirement is EUR 256,269 and USD 453,399 under seller warranty. Norda has considered the claim with the assistance of legal counsel and considers the claim as unfounded. It is believed that the dispute will be decided by a tribunal in 2013.
Latest Developments for Diasorin SpA
- DiaSorin SpA Confirms FY 2013 Revenues and EBITDA Guidance
- DiaSorin SpA Announces FDA Approval of Aldosterone Assay on CLIA; FDA Approval of TSH and fT4
- DiaSorin SpA Proposes to Distribute Dividend for FY 2012; Issues FY 2013 Revenues and EBITDA Guidance Below Analysts' Estimates
- DiaSorin SpA Proposes Distribution of Extraordinary Dividend; Confirms FY 2012 Revenues and EBITDA Margin Guidance
Latest Key Developments in Medical
- Urban Ag Corp Announces It Has Entered Into The Final Stages Of Negotiations To Acquire Contractor Currently Generating $4,500,000 In Revenues
- HeartWare International Inc Receives Conditional Approval From FDA To Enroll Supplemental Patient Cohort In Destination Therapy Trial
- Euromedis Groupe SA Issues FY 2013 Revenue Guidance In Line with Analysts' Estimates; Comments on Operating Income Guidance
- MEGANESUPER CO LTD Announces Changes of President
- Share this
- Link this
- Digg this
Follow Reuters